Gene therapy for malignant mesothelioma: beyond the infant years.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 897, doi. 10.1038/sj.cgt.7700935
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2006 AND VI 13 AND IP 10
Results: 8
1
2
Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 940, doi. 10.1038/sj.cgt.7700958
- By:
- Publication type:
- Article
3
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 905, doi. 10.1038/sj.cgt.7700961
- By:
- Publication type:
- Article
4
Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 919, doi. 10.1038/sj.cgt.7700966
- By:
- Publication type:
- Article
5
Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 930, doi. 10.1038/sj.cgt.7700967
- By:
- Publication type:
- Article
6
Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 948, doi. 10.1038/sj.cgt.7700968
- By:
- Publication type:
- Article
7
Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 958, doi. 10.1038/sj.cgt.7700972
- By:
- Publication type:
- Article
8
Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 10, p. 969, doi. 10.1038/sj.cgt.7700973
- By:
- Publication type:
- Article